131 related articles for article (PubMed ID: 9449216)
1. The effects of diabetes on placental aromatase activity.
McRobie DJ; Korzekwa KR; Glover DD; Tracy TS
J Steroid Biochem Mol Biol; 1997; 63(1-3):147-53. PubMed ID: 9449216
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
3. Human placental estrogen synthetase (aromatase). Effect of environment on the kinetics of protein-protein and substrate-protein interactions and the production of 19-oxygenated androgen intermediates in the purified reconstituted cytochrome P450 enzyme system.
Sethumadhavan K; Bellino FL
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):381-94. PubMed ID: 1911429
[TBL] [Abstract][Full Text] [Related]
4. [Estrogen formation in the central nervous system and characteristics of aromatase of rat hypothalamus].
Takezawa Y; Fukabori Y; Honma S
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):96-110. PubMed ID: 2040368
[TBL] [Abstract][Full Text] [Related]
5. Modulation of aromatase and P450 cholesterol side-chain cleavage enzyme activities of human placental cytotrophoblasts by insulin and insulin-like growth factor I.
Nestler JE
Endocrinology; 1987 Nov; 121(5):1845-52. PubMed ID: 3311719
[TBL] [Abstract][Full Text] [Related]
6. 19-oxygenations of 3-deoxy androgens, potent competitive inhibitors of estrogen biosynthesis, with human placental aromatase.
Numazawa M; Nagaoka M; Morio M; Kamiyama T
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):173-9. PubMed ID: 10704906
[TBL] [Abstract][Full Text] [Related]
7. Purification and reconstitution properties of human placental aromatase. A cytochrome P-450-type monooxygenase.
Tan L; Muto N
Eur J Biochem; 1986 Apr; 156(2):243-50. PubMed ID: 3084250
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
Numazawa M; Mutsumi A; Tachibana M
Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
[TBL] [Abstract][Full Text] [Related]
9. Aromatization of 16alpha-hydroxyandrostenedione by human placental microsomes: effect of preincubation with suicide substrates of androstenedione aromatization.
Numazawa M; Tachibana M; Mutsumi A; Yoshimura A; Osawa Y
J Steroid Biochem Mol Biol; 2002 Jun; 81(2):165-72. PubMed ID: 12137807
[TBL] [Abstract][Full Text] [Related]
10. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
Almadhidi J; Moslemi S; Drosdowsky MA; Séralini GE
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
[TBL] [Abstract][Full Text] [Related]
11. Porcine gonadal and placental isozymes of aromatase cytochrome P450: sub-cellular distribution and support by NADPH-cytochrome P450 reductase.
Corbin CJ; Trant JM; Conley AJ
Mol Cell Endocrinol; 2001 Feb; 172(1-2):115-24. PubMed ID: 11165045
[TBL] [Abstract][Full Text] [Related]
12. P-450(11beta)-dependent conversion of androgen to estrogen, the aromatase reaction.
Suhara K; Ohashi K; Takeda K; Katagiri M
Biochem Biophys Res Commun; 1986 Oct; 140(2):530-5. PubMed ID: 3490848
[TBL] [Abstract][Full Text] [Related]
13. Use of aromatase (CYP19) metabolite ratios to characterize electron transfer from NADPH-cytochrome P450 reductase.
Grogan J; Shou M; Zhou D; Chen S; Korzekwa KR
Biochemistry; 1993 Nov; 32(45):12007-12. PubMed ID: 8218277
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterization of human placental aromatase cytochrome P-450.
Kellis JT; Vickery LE
J Biol Chem; 1987 Mar; 262(9):4413-20. PubMed ID: 3104339
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase.
Bednarski PJ; Nelson SD
J Steroid Biochem; 1989 Feb; 32(2):309-16. PubMed ID: 2921872
[TBL] [Abstract][Full Text] [Related]
16. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
Furth PS; Robinson CH
Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
[TBL] [Abstract][Full Text] [Related]
17. Conversion of 19-oxo[2 beta-2H]androgens into oestrogens by human placental aromatase. An unexpected stereochemical outcome.
Cole PA; Robinson CH
Biochem J; 1990 Jun; 268(3):553-61. PubMed ID: 2363692
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts.
Nestler JE
Endocrinology; 1990 Nov; 127(5):2064-70. PubMed ID: 2226300
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
20. Stereochemistry of estrogen biosynthesis by a reconstituted aromatase cytochrome P-450 preparation from human placenta.
Muto N; Tan L
Biochem Biophys Res Commun; 1986 Apr; 136(2):454-62. PubMed ID: 3707583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
